Advertisement

The Role of the Renin-Angiotensin System in Hepatic Fibrosis

  • J.S. Lubel
  • F.J. Warner
  • P.W. Angus
Chapter
  • 306 Downloads
Part of the Proteases in Biology and Disease book series (PBAD, volume 7)

Keywords

Angiotensin Convert Enzyme Angiotensin Convert Enzyme Inhibitor Hepatic Fibrosis Hepatic Stellate Cell Bile Duct Ligation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Admiraal PJ, Derkx FH, Danser AH, Pieterman H and Schalekamp MA 1990 Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension Hypertension 15 1 44–55PubMedGoogle Scholar
  2. Ardaillou R 1997 Active fragments of angiotensin II: enzymatic pathways of synthesis and biological effects Curr Opin Nephrol Hypertens 6 1 28–34PubMedGoogle Scholar
  3. Arroyo V, Bosch J, Mauri M, Viver J, Mas A, Rivera F and Rodes J 1979 Renin, aldosterone and renal haemodynamics in cirrhosis with ascites Eur J Clin Invest 9 1 69–73PubMedGoogle Scholar
  4. Arthur MJ 2000 Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis Am J Physiol Gastrointest Liver Physiol 279 2 G245–9PubMedGoogle Scholar
  5. Asbert M, Jimenez W, Gaya J, Gines P, Arroyo V, Rivera F and Rodes J 1992 Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin J Hepatol 15 1-2 179–83PubMedGoogle Scholar
  6. Basso N and Terragno NA 2001 History about the discovery of the renin-angiotensin system Hypertension 38 6 1246–9PubMedGoogle Scholar
  7. Bataller R, Gabele E, Parsons CJ, Morris T, Yang L, Schoonhoven R, Brenner DA and Rippe RA 2005 Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats Hepatology 41 5 1046–55PubMedGoogle Scholar
  8. Bataller R, Gines P, Nicolas JM, Gorbig MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V and Rodes J 2000 Angiotensin II induces contraction and proliferation of human hepatic stellate cells Gastroenterology 118 6 1149–56PubMedGoogle Scholar
  9. Bataller R, Sancho-Bru P, Gines P and Brenner DA 2005 Liver fibrogenesis: a new role for the renin-angiotensin system Antioxid Redox Signal 7 9-10 1346–55PubMedGoogle Scholar
  10. Bataller R, Sancho-Bru P, Gines P, Lora JM, Al-Garawi A, Sole M, Colmenero J, Nicolas JM, Jimenez W, Weich N, Gutierrez-Ramos JC, Arroyo V and Rodes J 2003 Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II Gastroenterology 125 1 117–25PubMedGoogle Scholar
  11. Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J, Qian T, Schoonhoven R, Hagedorn CH, Lemasters JJ and Brenner DA 2003 NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis J Clin Invest 112 9 1383–94PubMedGoogle Scholar
  12. Benter IF, Ferrario CM, Morris M and Diz DI 1995 Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats Am J Physiol 269 1 Pt 2 H313–9PubMedGoogle Scholar
  13. Bosch J, Arroyo V, Betriu A, Mas A, Carrilho F, Rivera F, Navarro-Lopez F and Rodes J 1980 Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis Gastroenterology 78 1 92–9PubMedGoogle Scholar
  14. Brasier AR, Li J and Copland A 1994 Transcription factors modulating angiotensinogen gene expression in hepatocytes Kidney Int 46 6 1564–6PubMedGoogle Scholar
  15. Brosnihan KB, Li P and Ferrario CM 1996 Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide Hypertension 27 3 Pt 2 523–8PubMedGoogle Scholar
  16. Burrell LM, Johnston CI, Tikellis C and Cooper ME 2004 ACE2, a new regulator of the renin-angiotensin system Trends Endocrinol Metab 15 4 166–9PubMedGoogle Scholar
  17. Cassiman D and Roskams T 2002 Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research J Hepatol 37 4 527–35PubMedGoogle Scholar
  18. Castro CH, Santos RA, Ferreira AJ, Bader M, Alenina N and Almeida AP 2005 Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart Hypertension 46 4 937–42PubMedGoogle Scholar
  19. Collister JP and Hendel MD 2003 The role of Ang (1-7) in mediating the chronic hypotensive effects of losartan in normal rats J Renin Angiotensin Aldosterone Syst 4 3 176–9PubMedGoogle Scholar
  20. Corpechot C, Barbu V, Wendum D, Kinnman N, Rey C, Poupon R, Housset C and Rosmorduc O 2002 Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis Hepatology 35 5 1010–21PubMedGoogle Scholar
  21. Croquet V, Moal F, Veal N, Wang J, Oberti F, Roux J, Vuillemin E, Gallois Y, Douay O, Chappard D and Cales P 2002 Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension J Hepatol 37 6 773–80PubMedGoogle Scholar
  22. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE and Acton S 2000 A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 Circ Res 87 5 E1–9PubMedGoogle Scholar
  23. Enomoto N, Ikejima K, Bradford BU, Rivera CA, Kono H, Goto M, Yamashina S, Schemmer P, Kitamura T, Oide H, Takei Y, Hirose M, Shimizu H, Miyazaki A, Brenner DA, Sato N and Thurman RG 2000 Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury J Gastroenterol Hepatol 15 Suppl D20–5PubMedGoogle Scholar
  24. Fernandes L, Fortes ZB, Nigro D, Tostes RC, Santos RA and Catelli De Carvalho MH 2001 Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo Hypertension 37 2 Part 2 703–9PubMedGoogle Scholar
  25. Ferrario CM 2003 Commentary on Tikellis et al: There is more to discover about angiotensin-converting enzyme Hypertension 41 3 390–1PubMedGoogle Scholar
  26. Ferreira AJ, Santos RA and Almeida AP 2001 Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion Hypertension 38 3 Pt 2 665–8PubMedGoogle Scholar
  27. Ferreira AJ, Santos RA and Almeida AP 2002 Angiotensin-(1-7) improves the post-ischemic function in isolated perfused rat hearts Braz J Med Biol Res 35 9 1083–90PubMedGoogle Scholar
  28. Freeman EJ, Chisolm GM, Ferrario CM and Tallant EA 1996 Angiotensin-(1-7) inhibits vascular smooth muscle cell growth Hypertension 28 1 104–8PubMedGoogle Scholar
  29. Friedman SL, Maher JJ and Bissell DM 2000 Mechanisms and therapy of hepatic fibrosis: report of the AASLD Single Topic Basic Research Conference Hepatology 32 6 1403–8PubMedGoogle Scholar
  30. Gorelik G, Carbini LA and Scicli AG 1998 Angiotensin 1-7 induces bradykinin-mediated relaxation in porcine coronary artery J Pharmacol Exp Ther 286 1 403–10PubMedGoogle Scholar
  31. Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK and Katovich M 2006 Prevention of Angiotensin II-Induced Cardiac Remodeling by Angiotensin-(1-7) Am J Physiol Heart Circ Physiol Google Scholar
  32. Grobe JL, Mecca AP, Mao H and Katovich MJ 2006 Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension Am J Physiol Heart Circ Physiol 290 6 H2417–23PubMedGoogle Scholar
  33. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis GJ and van Goor H 2004 Tissue distribution of ACE 2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis J Pathol 203 2 631–7PubMedGoogle Scholar
  34. Harmer D, Gilbert M, Borman R and Clark KL 2002 Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme FEBS Lett 532 1-2 107–10PubMedGoogle Scholar
  35. Herath CB, Warner FJ, Lubel JS, Dean R, Lew RA, Smith AI, Burrell LM and Angus PW 2006 The balance between hepatic ACE2 and ACE determines plasma levels of vasodilator peptide angiotensin (1-7) in experimental biliary fibrosis Journal of Gastroenterology and Hepatology 21 Suppl. 4 A325Google Scholar
  36. Ikura Y, Ohsawa M, Shirai N, Sugama Y, Fukushima H, Suekane T, Hirayama M, Ehara S, Naruko T and Ueda M 2005 Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension Hepatol Res 32 2 107–16PubMedGoogle Scholar
  37. Iwata M, Cowling RT, Gurantz D, Moore C, Zhang S, Yuan JX and Greenberg BH 2005 Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects Am J Physiol Heart Circ Physiol 289 6 H2356–63PubMedGoogle Scholar
  38. Iyer SN, Ferrario CM and Chappell MC 1998 Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system Hypertension 31 1 Pt 2 356–61PubMedGoogle Scholar
  39. Iyer SN, Yamada K, Diz DI, Ferrario CM and Chappell MC 2000 Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system J Cardiovasc Pharmacol 36 1 109–17PubMedGoogle Scholar
  40. Jamaluddin M, Meng T, Sun J, Boldogh I, Han Y and Brasier AR 2000 Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-kappaB activation Mol Endocrinol 14 1 99–113PubMedGoogle Scholar
  41. Jonsson JR, Clouston AD, Ando Y, Kelemen LI, Horn MJ, Adamson MD, Purdie DM and Powell EE 2001 Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis Gastroenterology 121 1 148–55PubMedGoogle Scholar
  42. Kallis Y, Alison MR and Forbes SJ 2006 Bone marrow stem cells and liver disease Gut Google Scholar
  43. Kanno K, Tazuma S and Chayama K 2003 AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl(4) Biochem Biophys Res Commun 308 1 177–83PubMedGoogle Scholar
  44. Kanno K, Tazuma S, Nishioka T, Hyogo H and Chayama K 2005 Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression Dig Dis Sci 50 5 942–8PubMedGoogle Scholar
  45. Knittel T, Mehde M, Kobold D, Saile B, Dinter C and Ramadori G 1999 Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1 J Hepatol 30 1 48–60PubMedGoogle Scholar
  46. Kojima H, Tsujimoto T, Uemura M, Takaya A, Okamoto S, Ueda S, Nishio K, Miyamoto S, Kubo A, Minamino N, Kangawa K, Matsuo H and Fukui H 1998 Significance of increased plasma adrenomedullin concentration in patients with cirrhosis J Hepatol 28 5 840–6PubMedGoogle Scholar
  47. Kono H, Rusyn I, Yin M, Gabele E, Yamashina S, Dikalova A, Kadiiska MB, Connor HD, Mason RP, Segal BH, Bradford BU, Holland SM and Thurman RG 2000 NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease J Clin Invest 106 7 867–72PubMedCrossRefGoogle Scholar
  48. Kostenis E, Milligan G, Christopoulos A, Sanchez-Ferrer CF, Heringer-Walther S, Sexton PM, Gembardt F, Kellett E, Martini L, Vanderheyden P, Schultheiss HP and Walther T 2005 G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor Circulation 111 14 1806–13PubMedGoogle Scholar
  49. Kucharewicz I, Chabielska E, Pawlak D, Matys T, Rolkowski R and Buczko W 2000 The antithrombotic effect of angiotensin-(1-7) closely resembles that of losartan J Renin Angiotensin Aldosterone Syst 1 3 268–72PubMedGoogle Scholar
  50. Kucharewicz I, Pawlak R, Matys T, Pawlak D and Buczko W 2002 Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7) Hypertension 40 5 774–9PubMedGoogle Scholar
  51. Kurikawa N, Suga M, Kuroda S, Yamada K and Ishikawa H 2003 An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells Br J Pharmacol 139 6 1085–94PubMedGoogle Scholar
  52. Lambert DW, Yarski M, Warner FJ, Thornhill P, Parkin ET, Smith AI, Hooper NM and Turner AJ 2005 Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2) J Biol Chem 280 34 30113–9PubMedGoogle Scholar
  53. Leung PS and Chappell MC 2003 A local pancreatic renin-angiotensin system: endocrine and exocrine roles Int J Biochem Cell Biol 35 6 838–46PubMedGoogle Scholar
  54. Leung PS, Suen PM, Ip SP, Yip CK, Chen G and Lai PB 2003 Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response Regul Pept 116 1-3 61–9PubMedGoogle Scholar
  55. Lew RA, Warner FJ, Hanchapola I and Smith AI 2006 Characterization of angiotensin converting enzyme-2 (ACE2) in human urine International Journal Of Peptide Research And Therapeutics 12 3 283–289Google Scholar
  56. Li P, Chappell MC, Ferrario CM and Brosnihan KB 1997 Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide Hypertension 29 1 Pt 2 394–400PubMedGoogle Scholar
  57. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H and Farzan M 2003 Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 6965 450–4PubMedGoogle Scholar
  58. Li X, Meng Y, Yang XS, Zhang ZS, Wu PS and Zou JL 2004 [Perindopril attenuates the progression of CCl4-inducing rat hepatic fibrosis] Zhonghua Gan Zang Bing Za Zhi 12 1 32–4PubMedGoogle Scholar
  59. Li X, Meng Y, Zhang ZS, Yang XS and Wu PS 2003 [Effect of ACE-I and AT-1 receptor blocker on the progression of CCl(4)-inducing rat hepatic fibrogenesis] Zhonghua Yi Xue Za Zhi 83 14 1241–5PubMedGoogle Scholar
  60. Lodato F, Mazzella G, Festi D, Azzaroli F, Colecchia A and Roda E 2006 Hepatocellular carcinoma prevention: A worldwide emergence between the opulence of developed countries and the economic constraints of developing nations World J Gastroenterol 12 45 7239–49PubMedGoogle Scholar
  61. Lubel JS, Herath CB, Warner FJ, Jia ZY, Burrell LM and Angus PW 2006 Upregulation of the ACE2/Ang(1-7)/Mas receptor axis in the bile duct ligation (BDL) model of hepatic fibrosis does not affect hepatic sinusoidal resistance Journal of Gastroenterology and Hepatology 21 Suppl 4 A332Google Scholar
  62. Marra F, DeFranco R, Grappone C, Milani S, Pastacaldi S, Pinzani M, Romanelli RG, Laffi G and Gentilini P 1998 Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration Am J Pathol 152 2 423–30PubMedGoogle Scholar
  63. McAllister-Lucas LM, Ruland J, Siu K, Jin X, Gu S, Kim DS, Kuffa P, Kohrt D, Mak TW, Nunez G and Lucas PC 2006 CARMA3/Bcl10/MALT1-dependent NF-{kappa}B activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells Proc Natl Acad Sci U S A Google Scholar
  64. Miyoshi M, Nagata K, Imoto T, Goto O, Ishida A and Watanabe T 2003 ANG II is involved in the LPS-induced production of proinflammatory cytokines in dehydrated rats Am J Physiol Regul Integr Comp Physiol 284 4 R1092–7PubMedGoogle Scholar
  65. Morris BJ, Iwamoto HS and Reid IA 1979 Localization of angiotensinogen in rat liver by immunocytochemistry Endocrinology 105 3 796–800PubMedCrossRefGoogle Scholar
  66. Nabeshima Y, Tazuma S, Kanno K, Hyogo H, Iwai M, Horiuchi M and Chayama K 2006 Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis Biochem Biophys Res Commun 346 3 658–64PubMedGoogle Scholar
  67. Nakamoto H, Ferrario CM, Fuller SB, Robaczewski DL, Winicov E and Dean RH 1995 Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension Hypertension 25 4 Pt 2 796–802PubMedGoogle Scholar
  68. Ocaranza MP, Godoy I, Jalil JE, Varas M, Collantes P, Pinto M, Roman M, Ramirez C, Copaja M, Diaz-Araya G, Castro P and Lavandero S 2006 Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat Hypertension 48 4 572–8PubMedGoogle Scholar
  69. Ohishi T, Saito H, Tsusaka K, Toda K, Inagaki H, Hamada Y, Kumagai N, Atsukawa K and Ishii H 2001 Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats Hepatol Res 21 2 147–158PubMedGoogle Scholar
  70. Paizis G, Cooper ME, Schembri JM, Tikellis C, Burrell LM and Angus PW 2002 Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver Gastroenterology 123 5 1667–76PubMedGoogle Scholar
  71. Paizis G, Gilbert RE, Cooper ME, Murthi P, Schembri JM, Wu LL, Rumble JR, Kelly DJ, Tikellis C, Cox A, Smallwood RA and Angus PW 2001 Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis J Hepatol 35 3 376–85PubMedGoogle Scholar
  72. Paizis G, Tikellis C, Cooper ME, Schembri JM, Lew RA, Smith AI, Shaw T, Warner FJ, Zuilli A, Burrell LM and Angus PW 2005 Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2 Gut 54 12 1790–6PubMedGoogle Scholar
  73. Pereira RM, Dos Santos RA, Teixeira MM, Leite VH, Costa LP, da Costa Dias FL, Barcelos LS, Collares GB and Simoes ESAC 2006 The renin-angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1-7) J Hepatol Google Scholar
  74. Ramalho LN, Ramalho FS, Zucoloto S, Castro-e-Silva Junior O, Correa FM, Elias Junior J and Magalhaes JF 2002 Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis Hepatogastroenterology 49 48 1499–502PubMedGoogle Scholar
  75. Ramos SG, Montenegro AP, Goissis G and Rossi MA 1994 Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis Pathol Int 44 9 655–61PubMedCrossRefGoogle Scholar
  76. Rice GI, Jones AL, Grant PJ, Carter AM, Turner AJ and Hooper NM 2006 Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study Hypertension 48 5 914–20PubMedGoogle Scholar
  77. Rice GI, Thomas DA, Grant PJ, Turner AJ and Hooper NM 2004 Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism Biochem J 383 Pt 1 45–51PubMedGoogle Scholar
  78. Richoux JP, Cordonnier JL, Bouhnik J, Clauser E, Corvol P, Menard J and Grignon G 1983 Immunocytochemical localization of angiotensinogen in rat liver and kidney Cell Tissue Res 233 2 439–51PubMedGoogle Scholar
  79. Rimola A, Londono MC, Guevara G, Bruguera M, Navasa M, Forns X, Garcia-Retortillo M, Garcia-Valdecasas JC and Rodes J 2004 Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation Transplantation 78 5 686–91PubMedGoogle Scholar
  80. Rincon-Sanchez AR, Covarrubias A, Rivas-Estilla AM, Pedraza-Chaverri J, Cruz C, Islas-Carbajal MC, Panduro A, Estanes A and Armendariz-Borunda J 2005 PGE2 alleviates kidney and liver damage, decreases plasma renin activity and acute phase response in cirrhotic rats with acute liver damage Exp Toxicol Pathol 56 4-5 291–303PubMedGoogle Scholar
  81. Rivera-Huizar S, Rincon-Sanchez AR, Covarrubias-Pinedo A, Islas-Carbajal MC, Gabriel-Ortiz G, Pedraza-Chaverri J, Alvarez-Rodriguez A, Meza-Garcia E and Armendariz-Borunda J 2006 Renal dysfunction as a consequence of acute liver damage by bile duct ligation in cirrhotic rats Exp Toxicol Pathol 58 2-3 185–95PubMedGoogle Scholar
  82. Ron D, Brasier AR and Habener JF 1990 Transcriptional regulation of hepatic angiotensinogen gene expression by the acute-phase response Mol Cell Endocrinol 74 3 C97–104PubMedGoogle Scholar
  83. Russo FP, Alison MR, Bigger BW, Amofah E, Florou A, Amin F, Bou-Gharios G, Jeffery R, Iredale JP and Forbes SJ 2006 The bone marrow functionally contributes to liver fibrosis Gastroenterology 130 6 1807–21PubMedGoogle Scholar
  84. Sakata T, Takenaga N, Endoh T, Wada O and Matsuki K 1991 Diagnostic significance of serum angiotensin-converting enzyme activity in biochemical tests with special reference of chronic liver diseases Jpn J Med 30 5 402–7PubMedGoogle Scholar
  85. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R and Walther T 2003 Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas Proc Natl Acad Sci U S A 100 14 8258–63PubMedGoogle Scholar
  86. Sasaki K, Taniguchi M, Miyoshi M, Goto O, Sato K and Watanabe T 2005 Are transcription factors NF-kappaB and AP-1 involved in the ANG II-stimulated production of proinflammatory cytokines induced by LPS in dehydrated rats? Am J Physiol Regul Integr Comp Physiol 289 6 R1599–608PubMedGoogle Scholar
  87. Sawa H 1990 [Angiotensinogen: gene expression and protein localization in human tissues] Hokkaido Igaku Zasshi 65 2 189–99PubMedGoogle Scholar
  88. Schiavone MT, Santos RA, Brosnihan KB, Khosla MC and Ferrario CM 1988 Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide Proc Natl Acad Sci U S A 85 11 4095–8PubMedGoogle Scholar
  89. Schuppan D, Ruehl M, Somasundaram R and Hahn EG 2001 Matrix as a modulator of hepatic fibrogenesis Semin Liver Dis 21 3 351–72PubMedGoogle Scholar
  90. Sewnath ME, van der Poll T, van Noorden CJ, ten Kate FJ and Gouma DJ 2004 Cholestatic interleukin-6-deficient mice succumb to endotoxin-induced liver injury and pulmonary inflammation Am J Respir Crit Care Med 169 3 413–20PubMedGoogle Scholar
  91. Silva DM, Vianna HR, Cortes SF, Campagnole-Santos MJ, Santos RA and Lemos VS 2006 Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats Peptides Google Scholar
  92. Strawn WB, Ferrario CM and Tallant EA 1999 Angiotensin-(1-7) reduces smooth muscle growth after vascular injury Hypertension 33 1 Pt 2 207–11PubMedGoogle Scholar
  93. Tallant EA, Ferrario CM and Gallagher PE 2005 Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor Am J Physiol Heart Circ Physiol 289 4 H1560–6PubMedGoogle Scholar
  94. Thomas MC and Tikellis C 2005 ACE2; an ACE up the Sleeve Current enzyme inhibition 1 51–63Google Scholar
  95. Tigerstedt R BP 1898 Niere und Kreislauf Skand Arch Physiol. 8 223–271Google Scholar
  96. Timmermans PB, Benfield P, Chiu AT, Herblin WF, Wong PC and Smith RD 1992 Angiotensin II receptors and functional correlates Am J Hypertens 5 12 Pt 2 221S–235SPubMedGoogle Scholar
  97. Timmermans PB, Chiu AT, Herblin WF, Wong PC and Smith RD 1992 Angiotensin II receptor subtypes Am J Hypertens 5 6 Pt 1 406–10PubMedGoogle Scholar
  98. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G and Turner AJ 2000 A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase J Biol Chem 275 43 33238–43PubMedGoogle Scholar
  99. Toblli JE, Ferder L, Stella I, Angerosa M and Inserra F 2002 Enalapril prevents fatty liver in nephrotic rats J Nephrol 15 4 358–67PubMedGoogle Scholar
  100. Tuncer I, Ozbek H, Ugras S and Bayram I 2003 Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis Exp Toxicol Pathol 55 2-3 159–66PubMedGoogle Scholar
  101. Turner AJ 2003 Exploring the structure and function of zinc metallopeptidases: old enzymes and new discoveries Biochem Soc Trans 31 Pt 3 723–7PubMedGoogle Scholar
  102. Ueda S, Masumori-Maemoto S, Wada A, Ishii M, Brosnihan KB and Umemura S 2001 Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man J Hypertens 19 11 2001–9PubMedGoogle Scholar
  103. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A and Tummino P 2002 Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase J Biol Chem 277 17 14838–43PubMedGoogle Scholar
  104. Vlachogiannakos J, Tang AK, Patch D and Burroughs AK 2001 Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease Gut 49 2 303–8PubMedGoogle Scholar
  105. von Bohlen und Halbach O 2003 Angiotensin IV in the central nervous system Cell Tissue Res 311 1 1–9Google Scholar
  106. Walters PE, Gaspari TA and Widdop RE 2005 Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats Hypertension 45 5 960–6PubMedGoogle Scholar
  107. Wang XZ, Zhang LJ, Li D, Huang YH, Chen ZX and Li B 2003 Effects of transmitters and interleukin-10 on rat hepatic fibrosis induced by CCl4 World J Gastroenterol 9 3 539–43PubMedGoogle Scholar
  108. Warner FJ, Lew RA, Smith AI, Lambert DW, Hooper NM and Turner AJ 2005 Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells J Biol Chem 280 47 39353–62PubMedGoogle Scholar
  109. Warner FJ, Smith AI, Hooper NM and Turner AJ 2004 Angiotensin-converting enzyme-2: a molecular and cellular perspective Cell Mol Life Sci 61 21 2704–13PubMedGoogle Scholar
  110. Wei H, Li D, Lu H, Zhan Y, Wang Z, Huang X, Pan Q and Xu Q 2000 Effects of angiotensin II receptor blockade on hepatic fibrosis in rats Zhonghua Gan Zang Bing Za Zhi 8 5 302–4PubMedGoogle Scholar
  111. Wei HS, Lu HM, Li DG, Zhan YT, Wang ZR, Huang X, Cheng JL and Xu QF 2000 The regulatory role of AT 1 receptor on activated HSCs in hepatic fibrogenesis:effects of RAS inhibitors on hepatic fibrosis induced by CCl(4) World J Gastroenterol 6 6 824–828PubMedGoogle Scholar
  112. Wei YH, Jun L and Qiang CJ 2004 Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats Dig Dis Sci 49 10 1589–94PubMedGoogle Scholar
  113. Whalen R, Rockey DC, Friedman SL and Boyer TD 1999 Activation of rat hepatic stellate cells leads to loss of glutathione S-transferases and their enzymatic activity against products of oxidative stress Hepatology 30 4 927–33PubMedGoogle Scholar
  114. Yang L, Bataller R, Dulyx J, Coffman TM, Gines P, Rippe RA and Brenner DA 2005 Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice J Hepatol 43 2 317–23PubMedGoogle Scholar
  115. Yokohama S, Tokusashi Y, Nakamura K, Tamaki Y, Okamoto S, Okada M, Aso K, Hasegawa T, Aoshima M, Miyokawa N, Haneda M and Yoneda M 2006 Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis World J Gastroenterol 12 2 322–6PubMedGoogle Scholar
  116. Yokohama S, Yoneda M, Haneda M, Okamoto S, Okada M, Aso K, Hasegawa T, Tokusashi Y, Miyokawa N and Nakamura K 2004 Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis Hepatology 40 5 1222–5PubMedGoogle Scholar
  117. Yoshiji H, Kuriyama S and Fukui H 2002 Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor Tumour Biol 23 6 348–56PubMedGoogle Scholar
  118. Yoshiji H, Kuriyama S, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H and Fukui H 2001 The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor Clin Cancer Res 7 4 1073–8PubMedGoogle Scholar
  119. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H and Fukui H 2001 Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats Hepatology 34 4 Pt 1 745–50PubMedGoogle Scholar
  120. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Yanase K, Namisaki T, Yamazaki M, Tsujinoue H, Imazu H and Fukui H 2003 Angiotensin-II induces the tissue inhibitor of metalloproteinases-1 through the protein kinase-C signaling pathway in rat liver fibrosis development Hepatol Res 27 1 51–56PubMedGoogle Scholar
  121. Yoshiji H, Noguchi R and Fukui H 2005 Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C J Gastroenterol 40 2 215–6PubMedGoogle Scholar
  122. Yoshiji H, Noguchi R, Kuriyama S, Yoshii J and Ikenaka Y 2005 Combination of interferon and angiotensin-converting enzyme inhibitor, perindopril, suppresses liver carcinogenesis and angiogenesis in mice Oncol Rep 13 3 491–5PubMedGoogle Scholar
  123. Yoshiji H, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Imazu H, Yanase K, Kuriyama S and Fukui H 2002 Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats J Hepatol 37 1 22–30PubMedGoogle Scholar
  124. Yoshiji H, Yoshii J, Ikenaka Y, Noguchi R, Yanase K, Tsujinoue H, Imazu H and Fukui H 2002 Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells Int J Oncol 20 6 1227–31PubMedGoogle Scholar
  125. Zhang X, Yu WP, Gao L, Wei KB, Ju JL and Xu JZ 2004 Effects of lipopolysaccharides stimulated Kupffer cells on activation of rat hepatic stellate cells World J Gastroenterol 10 4 610–3PubMedGoogle Scholar
  126. Zhang Y, Yang X, Wu P, Xu L, Liao G and Yang G 2003 Expression of angiotensin II type 1 receptor in rat hepatic stellate cells and its effects on cell growth and collagen production Horm Res 60 3 105–10PubMedGoogle Scholar
  127. Zhang YJ, Yang XS, Wu PS, Li X, Zhang XF, Chen XQ and Yu ZX 2003 Effects of angiotensin II and losartan on the growth and proliferation of hepatic stellate cells Di Yi Jun Yi Da Xue Xue Bao 23 3 219–21, 227PubMedGoogle Scholar
  128. Zisman LS, Keller RS, Weaver B, Lin Q, Speth R, Bristow MR and Canver CC 2003 Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2 Circulation 108 14 1707–12PubMedGoogle Scholar
  129. Zisman LS, Meixell GE, Bristow MR and Canver CC 2003 Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate Circulation 108 14 1679–81PubMedGoogle Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • J.S. Lubel
    • 1
  • F.J. Warner
    • 2
  • P.W. Angus
    • 1
  1. 1.Department of GastroenterologyAustin HealthHeidelberg, MelbourneAustralia
  2. 2.A.W. Morrow Gastroenterology and Liver Centre, Centenary Institute of Cancer Medicine and Cell BiologyUniversity of SydneySydneyAustralia

Personalised recommendations